13/01/2022

EUROPE: 5 PhD positions on the MSCA-funded training network ALLODD (allostery in drug design)

Categories: opportunities

Tags: MSCA ITN | PhD fellowships


The ALLODD project is a collaboration between 13 academic and industrial organizations. The aim of ALLODD is to train a new generation of scientists to exploit the concept of allostery in drug design, putting together a whole array of technologies to identify and characterize allosteric modulators of protein function that will be applied to therapeutically relevant systems.

ALLODD provides a structured 3-year cutting-edge Research/PhD training programme in and beyond the fields of physical chemistry of biological systems, theoretical and computational chemistry, biological chemistry, biochemistry, targeted drug delivery/discovery and medicinal chemistry, in the following highly reputed organizations:
 
  1. BIOMEDICAL RESEARCH FOUNDATION ACADEMY OF ATHENS (BRFAA), Cournia Lab Greece
  2. FORSCHUNGSZENTRUM JULICH GMBH (FZJ), Rossetti Lab, Germany
  3. CHARITE – UNIVERSITAETSMEDIZIN BERLIN (Charité), Scheerer Lab, Germany
  4. KAROLINSKA INSTITUTET (KI), Zubarev Lab, Sweden
  5. UNIVERSITE DE STRASBOURG (Unistra), Cecchini Lab, France

The following eligibility rules apply for participation in a Marie Skłodowska Curie Innovative Training Network:

1) Research experience: Applicants for the ESR PhD positions should be in the first 4 years (full-time equivalent) of their research career and not yet have been awarded a doctorate. This 4-year period is measured from the date of obtaining the degree which would formally entitle to embark on a doctorate.

2) Mobility requirement: Applicants should not have resided or performed their main activity (work, studies, etc.) in the country of the host institution for more than 12 months in the 3-year period immediately prior to the start date of the PhD research.

In addition, local regulations of the host countries may apply.

Details & Application